(Q43913279)

28 November 2017

title

p53 codon 72 polymorphism and its association with bladder cancer (English)

1 reference

28 November 2017

4

Demetrios A Spandidos

1 reference

28 November 2017

Nikolaos Soulitzis

1

1 reference

28 November 2017

George Sourvinos

series ordinal

2

1 reference

28 November 2017

Despina N Dokianakis

series ordinal

3

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

179

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

175-183

1 reference

28 November 2017

cites work

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

Epidemiology and biology of human urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

Human papillomavirus-associated tumors of the skin and mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

Human papillomavirus and urological tumours: II. Role in bladder, prostate, renal and testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

Human papillomavirus DNA as a factor determining the survival of bladder cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

Low frequency of human papillomavirus infection in initial papillary bladder tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

The p53 pathway and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

p53 mutations in bladder tumors inactivate the transactivation of the p21 and Bax genes, and have a predictive value for the clinical outcome after bacillus Calmette-Guerin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

Primary structure polymorphism at amino acid residue 72 of human p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

Codon 72 polymorphism of p53 and its association with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

p53 polymorphism and risk of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

p53 codon 72 polymorphism and risk of cervical cancer in UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

p53 codon 72 polymorphism as a risk factor in the development of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

p53 Codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

Genetic detection of bladder cancer by microsatellite analysis of p16, RB1 and p53 tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

Identification of a novel p53 functional domain that is necessary for efficient growth suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

The polyproline region of p53 is required to activate apoptosis but not growth arrest.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

Two polymorphic variants of wild-type p53 differ biochemically and biologically

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

Is p53 polymorphism maintained by natural selection?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900867-9

7 January 2021

10.1016/S0304-3835(01)00867-9

Identifiers

DOI

1 reference

28 November 2017

1 reference